DOCSLIB.ORG

Pub 100-04 Medicare Claims Processing Centers for Medicare & Medicaid Services (CMS) Transmittal 10541 Date: December 31, 2020 Change Request 12120

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Pub 100-04 Medicare Claims Processing Centers for Medicare & Medicaid Services (CMS) Transmittal 10541 Date: December 31, 2020 Change Request 12120 Department of Health & CMS Manual System Human Services (DHHS) Pub 100-04 Medicare Claims Processing Centers for Medicare & Medicaid Services (CMS) Transmittal 10541 Date: December 31, 2020 Change Request 12120 SUBJECT: January 2021 Update of the Hospital Outpatient Prospective Payment System (OPPS) I. SUMMARY OF CHANGES: This Recurring Update Notification describes changes to and billing instructions for various payment policies implemented in the January 2021 OPPS update. The January 2021 Integrated Outpatient Code Editor (I/OCE) will reflect the Healthcare Common Procedure Coding System (HCPCS), Ambulatory Payment Classification (APC), HCPCS Modifier, and Revenue Code additions, changes, and deletions identified in this Change Request (CR). This Recurring Update Notification applies to Chapter 4, section 50.7. EFFECTIVE DATE: January 1, 2021 *Unless otherwise specified, the effective date is the date of service. IMPLEMENTATION DATE: January 4, 2021 Disclaimer for manual changes only: The revision date and transmittal number apply only to red italicized material. Any other material was previously published and remains unchanged. However, if this revision contains a table of contents, you will receive the new/revised information only, and not the entire table of contents. II. CHANGES IN MANUAL INSTRUCTIONS: (N/A if manual is not updated) R=REVISED, N=NEW, D=DELETED-Only One Per Row. R/N/D CHAPTER / SECTION / SUBSECTION / TITLE R 4/Table of Contents R 4/10.2/10.2.3/Comprehensive APCs N 4/10.2/10.2.4/Reporting for Certain Outpatient Department Services (That Are Similar to Therapy Services) (“Non-Therapy Outpatient Department Services”) and Are Adjunctive to Comprehensive APC Procedures III. FUNDING: For Medicare Administrative Contractors (MACs): The Medicare Administrative Contractor is hereby advised that this constitutes technical direction as defined in your contract. CMS does not construe this as a change to the MAC Statement of Work. The contractor is not obligated to incur costs in excess of the amounts allotted in your contract unless and until specifically authorized by the Contracting Officer. If the contractor considers anything provided, as described above, to be outside the current scope of work, the contractor shall withhold performance on the part(s) in question and immediately notify the Contracting Officer, in writing or by e-mail, and request formal directions regarding continued performance requirements. IV. ATTACHMENTS: Business Requirements Manual Instruction Attachment - Business Requirements Pub. 100-04 Transmittal: 10541 Date: December 31, 2020 Change Request: 12120 SUBJECT: January 2021 Update of the Hospital Outpatient Prospective Payment System (OPPS) EFFECTIVE DATE: January 1, 2021 *Unless otherwise specified, the effective date is the date of service. IMPLEMENTATION DATE: January 4, 2021 I. GENERAL INFORMATION A. Background: This Recurring Update Notification describes changes to and billing instructions for various payment policies implemented in the January 2021 OPPS update. The January 2021 Integrated Outpatient Code Editor (I/OCE) will reflect the Healthcare Common Procedure Coding System (HCPCS), Ambulatory Payment Classification (APC), HCPCS Modifier, and Revenue Code additions, changes, and deletions identified in this Change Request (CR). This Recurring Update Notification applies to chapter 4, section 50.7. The January 2021 revisions to I/OCE data files, instructions, and specifications are provided in the forthcoming January 2021 I/OCE CR. B. Policy: 1. Covid-19 Laboratory Tests and Services Coding Update Since February 2020, CMS has recognized several Covid-19 laboratory tests and related services. The codes are listed in Table 1, attachment A, along with their OPPS status indictors. The codes, along with their short descriptors and status indicators are also listed in the January 2021 OPPS Addendum B that is posted on the CMS website. For information on the OPPS status indicator definitions, refer to OPPS Addendum D1 of the CY 2021 OPPS/Ambulatory Surgical Center (ASC) final rule. CMS has established one HCPCS code, U0005, effective January 1, 2021. In addition, the AMA CPT Editorial Panel established five new CPT codes, specifically, CPT codes 87636, 87637, 87811, and 0240U and 0241U effective October 6, 2020. These codes were established too late to include in the October 2020 Update, so they are included in this January 2021 Update with the effective date of October 6, 2020. In addition, the AMA CPT Editorial Panel established CPT code 87428 effective November 10, 2020. Since it was established too late to include in the October 2020 Update, it is included in this January 2021 Update, with the effective date of November 10, 2020. 2. CPT Proprietary Laboratory Analyses (PLA) Coding Changes Effective October 6, 2020 and January 1, 2021 The AMA CPT Editorial Panel established 13 new PLA codes, specifically, CPT codes 0227U through 0239U, effective January 1, 2021. In addition, the AMA CPT Editorial Panel established two new PLA codes, specifically, CPT codes 0240U and 0241U effective October 6, 2020. Because CPT codes 0240U and 0241U were released on October 6, 2020, they were too late to include in the October 2020 OPPS update and are instead being included in the January 2021 update with an effective date of October 6, 2020. Table 2, attachment A, lists the long descriptors and status indicators for the codes. CPT codes 0227U through 0239U have been added to the January 2021 I/OCE with an effective date of January 1, 2021 while CPT codes 0240U and 0241U have been added to the January 2021 I/OCE with an effective date of October 6, 2020. These codes, along with their short descriptors, status indicators, and payment rates (where applicable) are also listed in the January 2021 OPPS Addendum B that is posted on the CMS website. For information on the OPPS status indicators, refer to OPPS Addendum D1 of the CY 2021 OPPS/ASC final rule for the latest definitions. 3. Monoclonal Antibody Therapy Product and Administration Codes On November 9, 2020, the U.S. Food and Drug Administration (FDA) issued an emergency use authorization (EUA) for the investigational monoclonal antibody therapy, bamlanivimab, for the treatment of mild to moderate COVID-19 in adults and pediatric patients with positive COVID-19 test results who are at high risk for progressing to severe COVID-19 and/or hospitalization. Bamlanivimab may only be administered in settings in which health care providers have immediate access to medications to treat a severe infusion reaction, such as anaphylaxis, and the ability to activate the emergency medical system (EMS), as necessary. On November 21, 2020, FDA issued an EUA for two monoclonal antibodies, specifically, casirivimab and imdevimab, that are administered together for the treatment of mild to moderate COVID-19 in adults and pediatric patients (12 years of age or older) with positive results of direct SARS-CoV-2 viral testing and who are at high risk for COVID-19. This includes those who are 65 years of age or older or who have certain chronic medical conditions. To ensure access to these monoclonal antibody treatments during the COVID-19 public health emergency (PHE), Medicare covers and pays for the infusion of monoclonal antibody therapy in accordance with Section 3713 of the Coronavirus Aid, Relief, and Economic Security Act (CARES Act). That is, as a result of the circumstances of the PHE, Medicare covers and pays for the infusion of monoclonal antibody therapy in the manner in which it will pay for COVID-19 vaccines and other statutory vaccines such as influenza. To track and pay appropriately for monoclonal antibodies used to treat COVID-19, CMS established new HCPCS codes M0239 and Q0239 effective November 9, 2020 for bamlanivimab, and new HCPCS codes M0243 and Q0243 effective November 21, 2020 for casirivimab and imdevimab. The codes have been added to the January 2021 I/OCE with their effective dates. Table 3, attachment A, lists the long descriptors for the codes. These codes, along with their short descriptors, status indicators, and payment rates (where applicable) are also listed in the January 2021 OPPS Addendum B that is posted on the CMS website. Similar to other vaccines, Medicare will not make a separate payment to the provider for a monoclonal antibody product when that product is given to the provider for free by the government. We anticipate much of the initial volume will be supplied to providers free of charge. Medicare established HCPCS code Q0239 for bamlanivimab and HCPCS code Q0243 for casirivimab and imdevimab (administered together). If HOPDs purchase bamlanivimab or casirivimab and imdevimab, they should report HCPCS codes Q0239 or Q0243, respectively, to receive separate payment for the monoclonal antibody treatments. Medicare will pay the provider for the administration of monoclonal antibodies regardless of whether the product is given to the provider for free. To receive separate payment for the infusion of bamlanivimab, HOPDs should report HCPCS code M0239. Similarly, to receive separate payment for the infusion of casirivimab and imdevimab, HOPDs should report HCPCS code M0243. For more information on the Medicare Monoclonal Antibody COVID-19 Infusion Program during the Public Health Emergency, refer to the following CMS websites: https://www.cms.gov/medicare/covid-19/monoclonal-antibody-covid-19-infusion https://www.cms.gov/medicare/covid-19/monoclonal-antibody-covid-19-infusion#Payment 4. New Covid-19 CPT Vaccines and Administration Codes On November 10, 2020, the AMA released six new CPT codes associated with the Pfizer and Moderna COVID-19 vaccines. Two of the six CPT codes (91300 and 91301) refer to the specific vaccine products, while the other four CPT codes (0001A, 0002A, 0011A and 0012A) describe the service to administer the vaccines. These codes will be available for use once the applicable coronavirus vaccine product receives Emergency Use Authorization (EUA) or approval from the Food and Drug Administration. The codes have been included in the January 2021 I/OCE. In addition, on December 17, 2020, the AMA released three new CPT codes associated with the AstraZeneca and University of Oxford COVID-19 vaccine.
Load more

Recommended publications
  • Microsurgery: Free Tissue Transfer and Replantation
    MICROSURGERY: FREE TISSUE TRANSFER AND REPLANTATION John R Griffin MD and James F Thornton MD HISTORY In 1964 Nakayama and associates15 reported In the late 1890s and early 1900s surgeons began what is most likely the first clinical series of free- approximating blood vessels, both in laboratory ani- tissue microsurgical transfers. The authors brought mals and human patients, without the aid of magni- vascularized intestinal segments to the neck for cer- fication.1,2 In 1902 Alexis Carrel3 described the vical esophageal reconstruction in 21 patients. The technique of triangulation for blood vessel anasto- intestinal segments were attached by direct microvas- mosis and advocated end-to-side anastomosis for cular anastomoses in vessels 3–4mm diam. Sixteen blood vessels of disparate size. Nylen4 first used a patients had a functional esophagus on follow-up of monocular operating microscope for human ear- at least 1y. drum surgery in 1921. Soon after, his chief, Two separate articles in the mid-1960s described Holmgren, used a stereoscopic microscope for the successful experimental replantation of rabbit otolaryngologic procedures.5 ears and rhesus monkey digits.16,17 Komatsu and 18 In 1960 Jacobson and coworkers,6 working with Tamai used a surgical microscope to do the first laboratory animals, reported microsurgical anasto- successful replantation of a completely amputated moses with 100% patency in carotid arteries as digit in 1968. That same year Krizek and associ- 19 small as 1.4mm diameter. In 1965 Jacobson7 was ates reported the first successful series of experi- able to suture vessels 1mm diam with 100% patency mental free-flap transfers in a dog model.
    [Show full text]
  • Unit Price Base Price Service Type Procedure
    University Physicians Group: Prices of Provider Services CPT Unit Base Service Procedure Modifier Code ype Current Procedural Terminology (CPT) Price Price T 00100 PR ANESTH,SALIVARY GLAND W/BX 1.00 5.00 Anesthesia 00102 PR ANESTH,CLEFT LIP REPAIR 1.00 6.00 Anesthesia 00103 PR ANESTH,BLEPHAROPLASTY 1.00 5.00 Anesthesia 00104 ANESTH,ELECTROSHOCK/ ECT 1.00 4.00 Anesthesia 00120 ANESTH,EAR SURGERY 1.00 5.00 Anesthesia 00124 ANESTH,EAR EXAM 1.00 4.00 Anesthesia 00126 PR ANESTH,TYMPANOTOMY 1.00 4.00 Anesthesia 00140 PR ANESTH,PROCEDURES ON EYE 1.00 5.00 Anesthesia 00142 ANESTH, LENS SURGERY 1.00 4.00 Anesthesia 00144 PR ANESTH,CORNEAL TRANSPLANT 1.00 6.00 Anesthesia 00145 ANESTH, VITREORETINAL SURG 1.00 6.00 Anesthesia 00147 PR ANESTH,IRIDECTOMY 1.00 4.00 Anesthesia 00148 ANESTH,EYE EXAM 1.00 4.00 Anesthesia 00160 PR ANESTH,NOSE,SINUS SURGERY 1.00 5.00 Anesthesia 00162 PR ANESTH,NOSE,RADICAL SINUS 1.00 7.00 Anesthesia SURGERY 00164 PR ANESTH,BIOPSY OF NOSE 1.00 4.00 Anesthesia 00170 PR ANESTH,PROCEDURE ON MOUTH 1.00 5.00 Anesthesia 00172 PR ANESTH,CLEFT PALATE REPAIR 1.00 6.00 Anesthesia 00174 PR ANESTH,EXCIS RETROPHARYNG 1.00 6.00 Anesthesia 00176 PR ANESTH,PHARYNX SURG 1.00 7.00 Anesthesia 00190 PR ANESTH,FACIAL BONE SURGERY 1.00 5.00 Anesthesia 00192 PR ANESTH,RADICAL FACIAL BONE 1.00 7.00 Anesthesia SURGERY 00210 PR ANESTH,OPEN HEAD SURGERY 1.00 11.00 Anesthesia 00211 PR ANESTH, INTRACRANIAL 1.00 10.00 Anesthesia HEMATOMA EVACUATION 00212 PR ANESTH,SKULL SURG SUBDUR 1.00 5.00 Anesthesia 00214 PR ANESTH,SKULL SURG BURR 1.00 9.00 Anesthesia
    [Show full text]
  • Code Procedure Cpt Price University Physicians Group
    UNIVERSITY PHYSICIANS GROUP (UPG) PRICES OF PROVIDER SERVICES CODE PROCEDURE MOD CPT PRICE 0001A IMM ADMN SARSCOV2 30MCG/0.3ML DIL RECON 1ST DOSE 0001A $40.00 0002A IMM ADMN SARSCOV2 30MCG/0.3ML DIL RECON 2ND DOSE 0002A $40.00 0011A IMM ADMN SARSCOV2 100 MCG/0.5 ML 1ST DOSE 0011A $40.00 0012A IMM ADMN SARSCOV2 100 MCG/0.5 ML 2ND DOSE 0012A $40.00 0021A IMM ADMN SARSCOV2 5X1010 VP/0.5 ML 1ST DOSE 0021A $40.00 0022A IMM ADMN SARSCOV2 5X1010 VP/0.5 ML 2ND DOSE 0022A $40.00 0031A IMM ADMN SARSCOV2 AD26 5X10^10 VP/0.5 ML 1 DOSE 0031A $40.00 0042T CEREBRAL PERFUS ANALYSIS, CT W/CONTRAST 0042T $954.00 0054T BONE SURGERY USING COMPUTER ASSIST, FLURO GUIDED 0054T $640.00 0055T BONE SURGERY USING COMPUTER ASSIST, CT/ MRI GUIDED 0055T $1,188.00 0071T U/S LEIOMYOMATA ABLATE <200 CC 0071T $2,500.00 0075T 0075T PR TCAT PLMT XTRC VRT CRTD STENT RS&I PRQ 1ST VSL 26 26 $2,208.00 0126T CAROTID INT-MEDIA THICKNESS EVAL FOR ATHERSCLER 0126T $55.00 0159T 0159T COMPUTER AIDED BREAST MRI 26 26 $314.00 PR RECTAL TUMOR EXCISION, TRANSANAL ENDOSCOPIC 0184T MICROSURGICAL, FULL THICK 0184T $2,315.00 0191T PR ANT SEGMENT INSERTION DRAINAGE W/O RESERVOIR INT 0191T $2,396.00 01967 ANESTH, NEURAXIAL LABOR, PLAN VAG DEL 01967 $2,500.00 01996 PR DAILY MGMT,EPIDUR/SUBARACH CONT DRUG ADM 01996 $285.00 PR PERQ SAC AGMNTJ UNI W/WO BALO/MCHNL DEV 1/> 0200T NDL 0200T $5,106.00 PR PERQ SAC AGMNTJ BI W/WO BALO/MCHNL DEV 2/> 0201T NDLS 0201T $9,446.00 PR INJECT PLATELET RICH PLASMA W/IMG 0232T HARVEST/PREPARATOIN 0232T $1,509.00 0234T PR TRANSLUMINAL PERIPHERAL ATHERECTOMY, RENAL
    [Show full text]
  • Psi Technical Specs V31.Pdf
    AHRQ Quality Indicators Patient Safety Indicators: Technical Specifications Department of Health and Human Services Agency for Healthcare Research and Quality http://www.qualityindicators.ahrq.gov March 2003 Version 3.1 (March 12, 2007) AHRQ Quality Indicators Web Site: http://www.qualityindicators.ahrq.gov Table of Contents About the Patient Safety Indicators ............................................................................................................... 1 Patient Safety Indicators – Detailed Definitions ............................................................................................ 3 Complications of Anesthesia (PSI 1) ............................................................................................................ 3 Death in Low-Mortality DRGs (PSI 2) ........................................................................................................... 5 Decubitus Ulcer (PSI 3) ................................................................................................................................. 7 Failure to Rescue (PSI 4) .............................................................................................................................. 9 Foreign Body Left during Procedure, Secondary Diagnosis Field (PSI 5 and 21)...................................... 17 Iatrogenic Pneumothorax, Secondary Diagnosis Field (PSI 6 and 22)....................................................... 18 Selected Infections Due to Medical Care, Secondary Diagnosis Field (PSI 7 and 23) .............................
    [Show full text]
  • Icd-9-Cm (2010)
    ICD-9-CM (2010) PROCEDURE CODE LONG DESCRIPTION SHORT DESCRIPTION 0001 Therapeutic ultrasound of vessels of head and neck Ther ult head & neck ves 0002 Therapeutic ultrasound of heart Ther ultrasound of heart 0003 Therapeutic ultrasound of peripheral vascular vessels Ther ult peripheral ves 0009 Other therapeutic ultrasound Other therapeutic ultsnd 0010 Implantation of chemotherapeutic agent Implant chemothera agent 0011 Infusion of drotrecogin alfa (activated) Infus drotrecogin alfa 0012 Administration of inhaled nitric oxide Adm inhal nitric oxide 0013 Injection or infusion of nesiritide Inject/infus nesiritide 0014 Injection or infusion of oxazolidinone class of antibiotics Injection oxazolidinone 0015 High-dose infusion interleukin-2 [IL-2] High-dose infusion IL-2 0016 Pressurized treatment of venous bypass graft [conduit] with pharmaceutical substance Pressurized treat graft 0017 Infusion of vasopressor agent Infusion of vasopressor 0018 Infusion of immunosuppressive antibody therapy Infus immunosup antibody 0019 Disruption of blood brain barrier via infusion [BBBD] BBBD via infusion 0021 Intravascular imaging of extracranial cerebral vessels IVUS extracran cereb ves 0022 Intravascular imaging of intrathoracic vessels IVUS intrathoracic ves 0023 Intravascular imaging of peripheral vessels IVUS peripheral vessels 0024 Intravascular imaging of coronary vessels IVUS coronary vessels 0025 Intravascular imaging of renal vessels IVUS renal vessels 0028 Intravascular imaging, other specified vessel(s) Intravascul imaging NEC 0029 Intravascular
    [Show full text]
  • FLEXOR TENOTOMY: a Simplified Technique
    CHAPTER 1 FLEXOR TENOTOMY: A Simplified Technique Mickey D. Stapp, DPM Craig Camasta, DPM INTRODUCTION The key to choosing this procedure is that the digital deformity must be flexible or semi-rigid at the interpha - Tenotomies have been performed in foot and ankle langeal joint level and no contracture or a reducible surgeries for many years. Traditionally, open tenotomies deformity at the metatarsophalangeal joint level. This were performed alone, in significant tendon contractures procedure cannot serve as an alternative for an arthrodesis without osseous involvement, or in combination with or arthroplasty of the digit or a full sequential release at the osseous surgery when osseous changes were also present. metatarsophalangeal joint. A percutaneous tenotomy for Many foot and ankle surgeons have understood the flexible digital deformities would be rarely indicated for importance of tenotomies in successful digital surgeries. 1-4 multiple adjacent digits. It is most often utilized on third McGowan may have been first to describe a minimally and fourth toes. invasive technique for tenotomies. 5 The lesion pattern, hyperkeratotic, preulcerative, or Surgeons searching for less invasive procedures to full ulcer, must be taken into consideration. The majority address tendon pathology began utilizing percutaneous of lesions best amenable to this procedure are lesions tenotomies for a multitude of various foot and ankle located at the distal aspect of the digit. This procedure deformities. The vast majority of these have been described provides a simplified technique to eliminate painful distal for clubfoot deformities. 6-8 Prior to the use of percutaneous clavi or recurring ulcerative lesions (Figure 1). tenotomies in clubfoot surgery, this technique was described for various Achilles tendonopathies.
    [Show full text]
  • 1 Annex 2. AHRQ ICD-9 Procedure Codes 0044 PROC-VESSEL
    Annex 2. AHRQ ICD-9 Procedure Codes 0044 PROC-VESSEL BIFURCATION OCT06- 0201 LINEAR CRANIECTOMY 0050 IMPL CRT PACEMAKER SYS 0202 ELEVATE SKULL FX FRAGMNT 0051 IMPL CRT DEFIBRILLAT SYS 0203 SKULL FLAP FORMATION 0052 IMP/REP LEAD LF VEN SYS 0204 BONE GRAFT TO SKULL 0053 IMP/REP CRT PACEMAKR GEN 0205 SKULL PLATE INSERTION 0054 IMP/REP CRT DEFIB GENAT 0206 CRANIAL OSTEOPLASTY NEC 0056 INS/REP IMPL SENSOR LEAD OCT06- 0207 SKULL PLATE REMOVAL 0057 IMP/REP SUBCUE CARD DEV OCT06- 0211 SIMPLE SUTURE OF DURA 0061 PERC ANGIO PRECEREB VES (OCT 04) 0212 BRAIN MENINGE REPAIR NEC 0062 PERC ANGIO INTRACRAN VES (OCT 04) 0213 MENINGE VESSEL LIGATION 0066 PTCA OR CORONARY ATHER OCT05- 0214 CHOROID PLEXECTOMY 0070 REV HIP REPL-ACETAB/FEM OCT05- 022 VENTRICULOSTOMY 0071 REV HIP REPL-ACETAB COMP OCT05- 0231 VENTRICL SHUNT-HEAD/NECK 0072 REV HIP REPL-FEM COMP OCT05- 0232 VENTRI SHUNT-CIRCULA SYS 0073 REV HIP REPL-LINER/HEAD OCT05- 0233 VENTRICL SHUNT-THORAX 0074 HIP REPL SURF-METAL/POLY OCT05- 0234 VENTRICL SHUNT-ABDOMEN 0075 HIP REP SURF-METAL/METAL OCT05- 0235 VENTRI SHUNT-UNINARY SYS 0076 HIP REP SURF-CERMC/CERMC OCT05- 0239 OTHER VENTRICULAR SHUNT 0077 HIP REPL SURF-CERMC/POLY OCT06- 0242 REPLACE VENTRICLE SHUNT 0080 REV KNEE REPLACEMT-TOTAL OCT05- 0243 REMOVE VENTRICLE SHUNT 0081 REV KNEE REPL-TIBIA COMP OCT05- 0291 LYSIS CORTICAL ADHESION 0082 REV KNEE REPL-FEMUR COMP OCT05- 0292 BRAIN REPAIR 0083 REV KNEE REPLACE-PATELLA OCT05- 0293 IMPLANT BRAIN STIMULATOR 0084 REV KNEE REPL-TIBIA LIN OCT05- 0294 INSERT/REPLAC SKULL TONG 0085 RESRF HIPTOTAL-ACET/FEM
    [Show full text]
  • Ipo) List for Cy 2021 (N=266)
    TABLE 31: PROPOSED MUSCULOSKELETAL-RELATED SERVICE REMOVALS FROM THE INPATIENT ONLY (IPO) LIST FOR CY 2021 (N=266) CY CY 2020 Long Descriptor Related Proposed Proposed 2020 Services CY 2021 CY 2021 CPT OPPS OPPS APC Code Status Assignment Indicator 0095T Removal of total disc arthroplasty 22856 N/A (artificial disc), anterior approach, each additional interspace, cervical (list separately in addition to code for primary procedure) 0098T Revision including replacement 22858 N/A of total disc arthroplasty (artificial disc), anterior approach, each additional interspace, cervical (list separately in addition to code for primary procedure) 0163T Total disc arthroplasty (artificial 22858 N/A disc), anterior approach, including discectomy to prepare interspace (other than for decompression), each additional interspace, lumbar (list separately in addition to code for primary procedure) 0164T Removal of total disc 22856 N/A arthroplasty, (artificial disc), anterior approach, each additional interspace, lumbar (list separately in addition to code for primary procedure) 0165T Revision including replacement 22858 N/A of total disc arthroplasty (artificial disc), anterior approach, each additional interspace, lumbar (list separately in addition to code for primary procedure) 0202T Posterior vertebral joint(s) 63030 J1 5115 arthroplasty (for example, facet joint[s] replacement), including facetectomy, laminectomy, foraminotomy, and vertebral column fixation, injection of bone cement, when performed, including fluoroscopy, single level, lumbar spine
    [Show full text]
  • Approved Surgical Procedures
    UNION MEDICAL BENEFITS SOCIETY LTD APPROVED SURGICAL PROCEDURES The following list of surgical procedures should be read in conjunction with your policy document. If you are intending to have one of the listed procedures, please call our surgical team on 0800 600 666 so we can guide you through the prior approval process. If a surgical procedure is not listed below, it will not be covered unless UniMed decides, in its sole discretion, to offer cover. CARDIAC GENERAL • Pericardiotomy Breast • Pericardiocentesis • Breast Cyst Aspiration or Needle Biopsy • Drainage of Pericaridal Effusion • Breast Biopsy • Coronary Artery Bypass (using vein or artery) • Core Biopsy of Breast • Open Repair of Atrial Septal Defect (ASD) • Excision Accessary Breast Tissue • Valvuloplasty • Mastectomy • Aortic/ Mitral Valve Replacement via Sternotomy • Sentinel Node Biopsy with/without Axillary Dissection • Pulmonary Valve Replacement via Sternotomy • Breast Microdochotomy • Tricuspid Valve Replacement via Sternotomy • Balloon Valvuloplasty – Mitral/ Aortic Reconstruction Post Mastectomy • Pacemaker Surgery – Initial Implantation (Excluding the Cost • Breast/ Nipple Reconstruction of the Pacemaker) • Nipple Areolar Tattoo • Removal of Sternal Wire • Maze Arrhythmia Surgery Gastrointestinal • Removal & Rewiring of Sternal Wire • Anal Sphincterotomy • Maze Arrhythmia Surgery (Standalone procedure) • Simple Repair of Anal Fistula – Special approval only • Maze Procedure – Thoracoscopic • Anal Fistula Repair with Mucosal Advancement Flap • Bentall’s Procedure (includes
    [Show full text]
  • Patient Care Curriculum: Hand Surgery Version 1.2 (October 2010)
    Patient Care Curriculum: Hand Surgery Version 1.2 (October 2010) Table of Contents TITLE 1 TABLE OF CONTENTS 2 GENERAL TOPICS 3 a. Anatomy/ Embryology b. Imaging c. Interpersonal Communication Skills d. Practice Based Learning e. Professionalism f. System Based Practice DEFINITIONS 3 SPECIFIC TOPICS 1. Amputations/ Finger tip injuries 4 2. Anesthesia, Pain Management 6 3. Arthritis 7 4. Burns 10 5. Combined Hand Injuries 11 6. Compartment Syndromes 12 7. Congenital Conditions 13 8. Contractures, Spasticity, Stiffness, Weakness 14 9. Dupuytren’s 15 10. Fractures/ dislocations/ nonunions/ malunions 17 11. Infections/Bites 31 12. Injection/Extravasation 33 13. Instability 34 14. Medical Conditions 38 15. Osteonecrosis 40 16. Peripheral Nerve 42 17. Psychological Aspects of Upper Extremity Conditions 46 18. Soft Tissue Defects 47 19. Tendon: Atraumatic conditions (tenosynovitis) 49 20. Tendon: Traumatic Conditions 52 21. Trauma/Critical Care 54 22. Tumors 55 23. Vascular Conditions 58 Sources 60 2 GENERAL TOPICS a. Anatomy/ Embryology b. Imaging c. Interpersonal Communication Skills d. Practice Based Learning: Evidence-Based Medicine e. Professionalism Medico-Legal Considerations f. System Based Practice Practice Management Rehabilitation The Public Medical System (Medicare, Medicaid, VA) DEFINITIONS DISEASES/CONDITIONS * BROAD - A graduate should be able to care for all aspects of disease and provide comprehensive management (ie carpal tunnel syndrome). * FOCUSED - A graduate should be able to make the diagnosis, provide initial management/stabilization, but will not be expected to be able to provide comprehensive management (ie traumatic segmental defect of the median nerve). OPERATIONS/PROCEDURES * ESSENTIAL -COMMON - Frequently performed\operations in hand surgery; specific procedure competency is required by end of training and should be attainable primarily by case volume (ie carpal tunnel release).
    [Show full text]
  • Soft Tissue Surgeries
    SOFT TISSUE SURGERIES MAMTA MANJARI SAHU, SR. PHYSIOTHERAPIST CUM JR. LECTURER TENDON TRANSFER - A tendon is removed from its normaldistal attachment and attached at another site. For example, the extensor indicis proprius (EIP) can be transferredif the EPL has ruptured. A flexor tendon can also betransferred to the dorsal surface of the hand to act as anextensor if multiple extensor tendons have ruptured. PHYSIOTHERAPY- Pre – operative therapy Patient education. Isolation and strengthening of donor tendon to get a grade of minimum 4 Suppling and ROM exercise for all the joints of involved part Post- operative therapy Active ROM of unsplinted digits, and other involved joints Begin active assisted movement of stabilized joints. Perform place and hold exercises by passively positioningthe operated part. splinting After 6 weeks Functional re-education of transferred tendon with and without faradic stimulation Isometric and dynamic, submaximal resistance exercises to improve functional strength and endurance of the transferred limb. Gentle passive stretching. Patient education. 171 TENDON REPAIR - The two ends of the rupturedtendon are re-opposed and sutured together. This optionis used only occasionally because the ends of the rupturedtendons are available in patients .Therefore, a considerable portion of the frayed tendon(s)must be resected, which shortens the tendon, making itdifficult to suture end-to-end. Post- operative physiotherapy 0-2weeks Pain relief Oedema control by compression, elevation Splinting to keep the tendon in relaxed positionPost- operative therapy Active ROM of unsplinted digits, and other involved joints Begin active assisted movement of stabilized joints. Perform place and hold exercises by passively positioning the operated part.
    [Show full text]
  • NOMESCO Classification of Surgical Procedures
    NOMESCO Classification of Surgical Procedures NOMESCO Classification of Surgical Procedures 87:2009 Nordic Medico-Statistical Committee (NOMESCO) NOMESCO Classification of Surgical Procedures (NCSP), version 1.14 Organization in charge of NCSP maintenance and updating: Nordic Centre for Classifications in Health Care WHO Collaborating Centre for the Family of International Classifications in the Nordic Countries Norwegian Directorate of Health PO Box 700 St. Olavs plass 0130 Oslo, Norway Phone: +47 24 16 31 50 Fax: +47 24 16 30 16 E-mail: [email protected] Website: www.nordclass.org Centre staff responsible for NCSP maintenance and updating: Arnt Ole Ree, Centre Head Glen Thorsen, Trine Fresvig, Expert Advisers on NCSP Nordic Reference Group for Classification Matters: Denmark: Søren Bang, Ole B. Larsen, Solvejg Bang, Danish National Board of Health Finland: Jorma Komulainen, Matti Mäkelä, National Institute for Health and Welfare Iceland: Lilja Sigrun Jonsdottir, Directorate of Health, Statistics Iceland Norway: Øystein Hebnes, Trine Fresvig, Glen Thorsen, KITH, Norwegian Centre for Informatics in Health and Social Care Sweden: Lars Berg, Gunnar Henriksson, Olafr Steinum, Annika Näslund, National Board of Health and Welfare Nordic Centre: Arnt Ole Ree, Lars Age Johansson, Olafr Steinum, Glen Thorsen, Trine Fresvig © Nordic Medico-Statistical Committee (NOMESCO) 2009 Islands Brygge 67, DK-2300 Copenhagen Ø Phone: +45 72 22 76 25 Fax: +45 32 95 54 70 E-mail: [email protected] Cover by: Sistersbrandts Designstue, Copenhagen Printed by: AN:sats - Tryk & Design a-s, Copenhagen 2008 ISBN 978-87-89702-69-8 PREFACE Preface to NOMESCO Classification of Surgical Procedures Version 1.14 The Nordic Medico-Statistical Committee (NOMESCO) published the first printed edition of the NOMESCO Classification of Surgical Procedures (NCSP) in 1996.
    [Show full text]